Európai Unió - román - EMA (European Medicines Agency)

sanofi winthrop industrie - clopidogrel sulfat acid - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - agenți antitrombotici - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. prevenirea aterotrombotice și tromboembolice în atrială fibrillationin pacienții adulți cu fibrilație atrială care au cel puțin un factor de risc de evenimente vasculare, nu sunt potrivite pentru tratamentul cu vitamina k antagoniști și care au un nivel scăzut riscul de sângerare, clopidogrelul este indicat în asociere cu aas pentru prevenirea aterotrombotice și tromboembolice, inclusiv accident vascular cerebral.

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novartis pharma gmbh - diclofenacum - draj. - 50mg - antiinflamatoare si antireumatice nesteroidiene derivati ai acidului acetic si substante inrudite

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

laropharm s.r.l. - romania - norfloxacinum - compr. film. - 400mg - chinolone antibacteriene fluorochinolone

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

labormed pharma sa - romania - norfloxacinum - compr. film. - 400mg - chinolone antibacteriene fluorochinolone

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ac helcor s.r.l. - romania - norfloxacinum - compr. film. - 400mg - chinolone antibacteriene fluorochinolone